Suppr超能文献

三种人类 GPCR 为了更高的表达和稳定性而进化。

Evolution of three human GPCRs for higher expression and stability.

机构信息

Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.

出版信息

J Mol Biol. 2011 May 13;408(4):599-615. doi: 10.1016/j.jmb.2011.02.051. Epub 2011 Mar 3.

Abstract

We recently developed a display method for the directed evolution of integral membrane proteins in the inner membrane of Escherichia coli for higher expression and stability. For the neurotensin receptor 1, a G-protein-coupled receptor (GPCR), we had evolved a mutant with a 10-fold increase in functional expression that largely retains wild-type binding and signaling properties and shows higher stability in detergent-solubilized form. We have now evolved three additional human GPCRs. Unmodified wild-type receptor cDNA was subjected to successive cycles of mutagenesis and fluorescence-activated cell sorting, and functional expression could be increased for all three GPCR targets. We also present a new stability screening method in a 96-well assay format to quickly identify evolved receptors showing increased thermal stability in detergent-solubilized form and rapidly evaluate them quantitatively. Combining the two methods turned out to be very powerful; even for the most challenging GPCR target--the tachykinin receptor NK(1), which is hardly expressed in E. coli and cannot be functionally solubilized--receptor mutants that are functionally expressed at 1 mg/l levels in E. coli and are stable in detergent solution could be quickly evolved. The improvements result from cumulative small changes in the receptor sequence. This combinatorial approach does not require preconceived notions for designing mutations. Our results suggest that this method is generally applicable to GPCRs. Existing roadblocks in structural and biophysical studies can now be removed by providing sufficient quantities of correctly folded and stable receptor protein.

摘要

我们最近开发了一种在大肠杆菌内膜中定向进化整合膜蛋白的显示方法,以提高表达和稳定性。对于神经降压素受体 1,一种 G 蛋白偶联受体 (GPCR),我们已经进化出一种功能表达增加 10 倍的突变体,该突变体在很大程度上保留了野生型结合和信号转导特性,并且在去污剂溶解形式下表现出更高的稳定性。我们现在已经进化了另外三个人类 GPCR。未经修饰的野生型受体 cDNA 经历了连续的突变和荧光激活细胞分选循环,所有三种 GPCR 靶标都可以增加功能表达。我们还提出了一种新的稳定性筛选方法,在 96 孔测定格式中,可以快速鉴定在去污剂溶解形式下显示出增加的热稳定性的进化受体,并快速定量评估它们。这两种方法的结合非常有效;即使对于最具挑战性的 GPCR 靶标——在大肠杆菌中几乎不表达且不能功能性溶解的速激肽受体 NK(1),也可以快速进化出在大肠杆菌中以 1mg/L 水平功能表达且在去污剂溶液中稳定的受体突变体。改进源于受体序列的累积微小变化。这种组合方法不需要预先设计突变的概念。我们的结果表明,该方法通常适用于 GPCR。通过提供足够数量的正确折叠和稳定的受体蛋白,可以消除结构和生物物理研究中的现有障碍。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验